Welcome to our dedicated page for Ovintiv SEC filings (Ticker: OVV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Ovintiv Inc. (OVV) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Ovintiv is an oil and natural gas exploration and production company with shares listed on the New York Stock Exchange, and its filings offer detailed insight into its operations in the United States and Canada, capital structure, risk factors and governance.
Investors can use Ovintiv’s periodic reports, such as its Annual Report on Form 10‑K and Quarterly Reports on Form 10‑Q, to review information on production volumes for oil, condensate, other NGLs and natural gas, operating and transportation costs, capital investment, non-GAAP measures like Non-GAAP Cash Flow and Non-GAAP Free Cash Flow, and leverage metrics such as Debt to EBITDA and Debt to Adjusted EBITDA. These filings also reference the company’s capital allocation framework, including dividends, share repurchases and long-term leverage targets.
Current reports on Form 8‑K are particularly important for tracking material events at Ovintiv. Recent 8‑K filings describe quarterly earnings releases and dividends, the renewal of a normal course issuer bid, a two-year term credit agreement intended to help finance the planned acquisition of NuVista Energy Ltd., the definitive arrangement agreement for that acquisition, and the Cedar LNG capacity agreement. Other 8‑K filings cover Board changes, annual meeting voting results and investor presentations.
Stock Titan’s platform surfaces these SEC filings with AI-powered summaries that highlight key points, helping users quickly understand the significance of lengthy documents. Real-time updates from EDGAR ensure that new Ovintiv filings, including 10‑K, 10‑Q, 8‑K and other forms, appear promptly. Users can also review disclosures related to non-GAAP measures, risk factors and forward-looking statements, and use the filings history to analyze how Ovintiv’s strategy, portfolio and financial profile have evolved over time.
Ovintiv Inc. director reported a routine equity change involving deferred share units. On 12/31/2025, the director acquired 408 Deferred Share Units (DSUs), each economically equivalent to one share of Ovintiv common stock. These DSUs were received as dividend equivalents in lieu of cash dividends for the fourth quarter of 2025 and will be held until the director retires from the Board.
Following this transaction, the director beneficially owned 54,019 derivative securities in the form of DSUs, held directly.
Ovintiv Inc. director reports dividend-equivalent deferred share units. A board member of Ovintiv Inc. filed a Form 4 showing an acquisition of 48 Deferred Share Units (DSUs) on 12/31/2025. Each DSU is the economic equivalent of one share of Ovintiv common stock and accrues dividend-equivalent DSUs, which are held until the director retires from the Board.
The 48 DSUs were received in lieu of cash dividends for the fourth quarter of 2025. Following this transaction, the director beneficially owns 6,377 derivative securities in the form of DSUs, held in direct ownership.
Ovintiv Inc.'s President & CEO, who also serves as a director, reported an equity transaction on 12/31/2025. The insider acquired 1,733 restricted share units (RSUs), each economically equivalent to one share of Ovintiv common stock. These RSUs were received as dividend equivalent RSUs in lieu of cash dividends for the fourth quarter of 2025.
The RSUs vest and become exercisable according to Ovintiv's Omnibus Incentive Plan and the applicable grant agreement, on the same schedule as the underlying RSUs and subject to continued employment with Ovintiv. Following this transaction, the insider beneficially owns 230,254 derivative securities, held directly.
Ovintiv Inc. reported an insider equity transaction by an executive officer. The reporting person, identified as an officer with the title EVP, M&M & GC, filed as a single reporting person for a transaction dated 12/31/2025. The filing shows an award of 354 restricted share units (RSUs) classified as derivative securities in Table II. Each RSU represents the economic equivalent of one share of Ovintiv common stock and includes dividend equivalent RSUs, vesting and becoming exercisable under Ovintiv’s Omnibus Incentive Plan and the applicable grant agreement, subject to continued employment. The 354 RSUs represent dividend equivalent RSUs received in lieu of cash dividends for the fourth quarter of 2025. Following this transaction, the reporting person beneficially owned 46,971 derivative securities in the form of RSUs, held as a direct ownership position.
Ovintiv Inc. director reported a routine equity compensation change involving deferred share units. On 12/31/2025, the director acquired 81 Deferred Share Units (DSUs), which are each the economic equivalent of one share of Ovintiv common stock. These DSUs were received as dividend equivalents in lieu of cash dividends for the fourth quarter of 2025 and will be held until the director retires from the Board.
Following this transaction, the director beneficially owns 10,702 derivative securities in the form of DSUs, held directly. The filing indicates the transaction was reported on behalf of the director under a power of attorney, reflecting standard insider reporting requirements rather than a discretionary open-market trade.
Ovintiv Inc. executive reports dividend-equivalent RSUs
Ovintiv Inc.'s EVP & COO reported receiving 630 restricted share units (RSUs) on 12/31/2025. These RSUs were granted as dividend-equivalent units in lieu of cash dividends for the fourth quarter of 2025 and are economically equal to 630 shares of Ovintiv common stock. The filing shows a total of 83,727 derivative securities beneficially owned after this transaction, all held directly. The RSUs will vest and become exercisable under Ovintiv's Omnibus Incentive Plan and the related grant agreement, subject to the executive's continued employment through the applicable exercise dates.
Ovintiv Inc. director reported a routine equity transaction involving deferred share units. On 12/31/2025, the director acquired 76 Deferred Share Units (DSUs), which are derivative securities that each represent the economic equivalent of one share of Ovintiv common stock and generate additional DSUs on dividends. These 76 DSUs were received as dividend equivalents in lieu of cash dividends for the fourth quarter of 2025. Following this transaction, the director beneficially owns 9,980 derivative securities in the form of DSUs, which are held until retirement from the Board.
Ovintiv Inc. director reports additional deferred share units from dividends. On 12/31/2025, the reporting person acquired 14 Deferred Share Units (DSUs), which are each the economic equivalent of one share of Ovintiv common stock and generate dividend-equivalent DSUs. These units were received in lieu of cash dividends for the fourth quarter of 2025 and are held until the director retires from the Board. Following this transaction, the director beneficially owns 1,860 DSUs on a direct basis.
Ovintiv Inc.'s Executive Vice President and Chief Financial Officer reported routine equity-based compensation tied to the company’s common stock. On 12/31/2025, the officer acquired 533 Restricted Share Units (RSUs), which are each economically equivalent to one share of Ovintiv common stock and include dividend-equivalent RSUs. Following this transaction, the officer held 70,483 RSUs in total.
The officer also acquired 22 Deferred Share Units (DSUs) on the same date, bringing total DSU holdings to 2,849 units. Both the RSUs and DSUs were credited as dividend equivalents received in lieu of cash dividends for the fourth quarter of 2025. RSU vesting and exercisability follow Ovintiv’s Omnibus Incentive Plan and the related grant agreement, while DSUs are held until retirement from the company.
Ovintiv Inc. executive reports dividend equivalent RSUs on Form 4. An officer of Ovintiv Inc., serving as EVP, Corporate Services, reported an acquisition of 276 restricted share units (RSUs) on 12/31/2025. Each RSU is the economic equivalent of one share of Ovintiv common stock and yields dividend equivalent RSUs.
The 276 RSUs were credited as dividend equivalent RSUs received in lieu of cash dividends for the fourth quarter of 2025, at a stated price of $0. Following this transaction, the reporting person beneficially owned 36,461 derivative securities in the form of RSUs, held directly. Vesting and exercise of these RSUs will occur under Ovintiv’s Omnibus Incentive Plan and the applicable grant agreement, subject to the executive’s continued employment through the relevant exercise dates.